首页> 外文期刊>Investigative ophthalmology & visual science >Evaluation of protein drug performance with vitreous humor in a novel ex-vivo intraocular model
【24h】

Evaluation of protein drug performance with vitreous humor in a novel ex-vivo intraocular model

机译:在新型离体眼内模型中评估玻璃体液的蛋白质药物性能

获取原文
获取外文期刊封面目录资料

摘要

Purpose: The stability of protein therapeutics during the residence time in the vitreous humor (VH) is an important consideration for intraocular treatment and can possibly impact therapeutic efficacy and treatment intervals. Not much attention has been paid to investigate the physical and chemical stability of therapeutic protein with VH components following intravitreal (IVT) delivery. It may be due to the unavailability of a reliable and representative in-vitro model for in-vivo conditions. Therefore in current study, we have developed and accessed a novel non-cell based Ex-vivo intravitreal (ExVit) model to study stability of proteins in simulated intraocular conditions. The ExVit model facilitated incubation of model proteins for desired period of time in simulated in-vivo conditions enabling the possibility to study protein-VH interactions. We have investigated various stability parameters such as levels of soluble and insoluble aggregates, amount of degradation products, and changes in the pH and osmolality at different time intervals. Methods: We have developed and evaluated three Ex-vivo intravitreal (ExVit) models, namely, ExVit static, semi-dynamic and dynamic. These models were utilized and compared when studying the in-vitro stability of model protein formulations under simulated intraocular conditions using porcine vitreous humor (VH). Samples were analyzed for turbidity, pH, aggregation, degradation products, osmolality and protein content. Results: The static model showed significant pH change likely due to degradation of the VH, making it an unsuitable model to investigate protein stability. The changes observed with added MAb are likely due to the impact of higher pH and/or VH degradation products. The ExVit semi-dynamic model effectively reduced/cleared the decomposition products of VH and maintained pH, however, it was unable to modulate diffusion rates. This restraint eventually limited its applicability to investigate long-term stability of proteins and their formulation following IVT injection. The ExVit dynamic model can be considered an advanced model which provides an opportunity to modulate the rate of diffusion, and Papp. Conclusions: The ExVit models have high potential to investigate the stability of proteins following intraocular injection and hence, choice of the right model is critical.
机译:目的:蛋白质治疗剂在玻璃体液(VH)停留时间内的稳定性是眼内治疗的重要考虑因素,可能会影响治疗效果和治疗间隔。在玻璃体内(IVT)递送后,研究具有VH成分的治疗性蛋白质的物理和化学稳定性并未引起太多关注。这可能是由于没有针对体内条件的可靠且具有代表性的体外模型。因此,在当前的研究中,我们已经开发并访问了一种基于非细胞的新型离体玻璃体内模型(ExVit),以研究模拟眼内条件下蛋白质的稳定性。 ExVit模型有助于在模拟体内条件下将模型蛋白温育所需时间,从而有可能研究蛋白-VH相互作用。我们研究了各种稳定性参数,例如可溶和不可溶聚集体的水平,降解产物的量以及在不同时间间隔的pH和重量克分子渗透压浓度的变化。方法:我们已经开发并评估了三种Ex-vivo玻璃体内(ExVit)模型,分别是静态,半动态和动态。在研究使用猪玻璃体液(VH)的模拟眼内条件下模型蛋白制剂的体外稳定性时,利用并比较了这些模型。分析样品的浊度,pH,聚集,降解产物,重量克分子渗透压浓度和蛋白质含量。结果:静态模型显示可能由于VH降解而导致pH值发生显着变化,使其不适用于研究蛋白质稳定性。添加MAb时观察到的变化可能是由于较高的pH和/或VH降解产物的影响。 ExVit半动力学模型可以有效地减少/清除VH的分解产物并保持pH值,但是它无法调节扩散速率。这种限制最终限制了其在IVT注射后研究蛋白质及其制剂的长期稳定性的适用性。可以将ExVit动态模型视为高级模型,它提供了一个机会来调节扩散速率和Papp。结论:ExVit模型具有很高的潜力来研究眼内注射后蛋白质的稳定性,因此,选择正确的模型至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号